# Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

> **NCT02517593** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 151 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** Polygenic Risk Score

## Key facts

- **NCT ID:** NCT02517593
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2020-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517593, "Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02517593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*